Reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=ptxp1YAqqNg

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of a recently published review investigating the effi...

Speaker: Naveen Pemmaraju, Institution: The University of Texas MD Anderson Cancer Center, Event: ASCO 2023, Format: Interview, Subject: Myeloproliferative Neoplasms, Subject: Myelofibrosis, Field: Clinical Practice, Field: Treatment, Medicines: Ruxolitinib
#############################